US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

109.77

+0.17880.16%

Post-market: 110.480.7032+0.64%19:30 EDT

Volume:14.72K

Turnover:1.63M

Market Cap:95.50M

PE:- -

High:112.13

Open:112.13

Low:109.77

Close:109.60

52wk High:126.40

52wk Low:55.34

Shares:870.00K

Float Shares:870.00K

Volume Ratio:1.17

T/O Rate:1.69%

Dividend:0.32

Dividend Rate:0.29%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Amgen to Present at Wells Fargo Healthcare Conference Webcast

Political and General News Events from September 2

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

Wall Street Analysts Are Bullish on Top Healthcare Picks

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.

FedEx Incheon Gateway Wins IATA CEIV Pharma Certification

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

Investors Shrug Off Good News for Heart Patients from New Meds

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

THOMSON REUTERS

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

UK Regulator Suspends Avacopan Vifor for New Patients

MT Newswires Live

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September

THOMSON REUTERS

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BIB/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"ProShares Ultra Nasdaq Biotechnology","latestPrice":109.7741,"timestamp":1789156800000,"preClose":109.5953,"halted":0,"volume":14723,"hourTrading":{"tag":"盘后","latestPrice":110.4773,"preClose":109.7741,"latestTime":"19:30 EDT","volume":18,"amount":1978.5564,"timestamp":1789169408018,"change":0.7032,"changeRate":0.006406,"amplitude":0},"delay":0,"changeRate":0.0016314568234222602,"floatShares":870000,"shares":870000,"eps":0,"marketStatus":"Market Closed","change":0.1788,"latestTime":"09-11 16:00:00 EDT","open":112.13,"high":112.13,"low":109.7741,"amount":1627925.702412,"amplitude":0.021496,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":109.5953,"sharesOutstanding":1040000,"nav":109.63,"aum":95378100,"dividendRate":0.002895,"bidAskSpread":0.002634,"postHourTrading":{"tag":"盘后","latestPrice":110.4773,"preClose":109.7741,"latestTime":"19:30 EDT","volume":18,"amount":1978.5564,"timestamp":1789169408018,"change":0.7032,"changeRate":0.006406,"amplitude":0},"volumeRatio":1.172362708296377,"impliedVol":0.4555,"impliedVolPercentile":0.5498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":870000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.172362708296377,"shares":870000,"dividePrice":0.3178,"high":112.13,"amplitude":0.021496,"preClose":109.5953,"low":109.7741,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":109.7741,"eps":0,"divideRate":0.002895,"volume":14723,"delay":0,"ttmEps":0,"open":112.13,"prevYearClose":79.7794,"prevWeekClose":119.9993,"prevMonthClose":116.5968,"prevQuarterClose":100.74,"fiveDayClose":121.9076,"twentyDayClose":107.5899,"sixtyDayClose":83.1128},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664096846","title":"Amgen to Present at Wells Fargo Healthcare Conference Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2664096846","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664096846?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:01","pubTimestamp":1788379299,"startTime":"0","endTime":"0","summary":"Amgen to present at Wells Fargo Healthcare Conference webcastAmgen will present at the 2026 Wells Fargo Healthcare Conference on Sept. 10, 2026 at 11:00 a.m. ET.Speakers include CFO Thomas Dittrich, C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL9RK355:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","AMGN","LU0058720904.USD","LU2242652126.USD","IE00BJT1NW94.SGD","IE0002141913.USD","IBB","LU0289739699.SGD","BK4599","LU2089984988.USD","TBXU","IBBQ","BBH","BK4588","IE00B2B36J28.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","BK4566","LU1571399168.USD","LU1057294990.SGD","LU1061106388.HKD","SG9999001440.SGD","LU2112291526.USD","PJP","LU0109394709.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","BIB","BK4534","LU0122379950.USD","LU2242646821.SGD","LU1023059063.AUD","BK4585","LU0868494617.USD","IE00B4R5TH58.HKD","BK4581","PBE","LU2468319806.SGD","BK4139","LU1983299246.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664197218","title":"Political and General News Events from September 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2664197218","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664197218?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:08","pubTimestamp":1788350892,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from September 2Sept 2 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U10K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU0889565916.HKD","IE00BJT1NW94.SGD","SG9999001440.SGD","AMGN","TBXU","IE0009355771.USD","BK4533","BK4581","LU0320765992.SGD","IE00BJJMRZ35.SGD","BK4566","LU0868494617.USD","BK4139","LU1023059063.AUD","IE00BFTCPJ56.SGD","BK4534","IE00B4R5TH58.HKD","BBH","IBB","LU0058720904.USD","IE00B2B36J28.USD","LU2242652126.USD","PJP","LU2112291526.USD","LU2242646821.SGD","PBE","LU0109394709.USD","LU2089984988.USD","LU2468319806.SGD","LU0122379950.USD","LU1983299246.USD","LU1571399168.USD","BK4585","LU1057294990.SGD","IE0002141913.USD","BK4599","BK4588","LU0289739699.SGD","BIB","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381433","title":"Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381433","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381433?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:23","pubTimestamp":1788348209,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) has drawn fresh investor attention after two recent regulatory decisions. The FDA approved Bixlenvo for virologically suppressed adults with HIV, and the European Commission cleared Trodelvy plus Keytruda for certain metastatic triple-negative breast cancer patients.\nThese approvals arrive after a strong run in Gilead Sciences' stock, with a 30-day share price return of 15.14% and a year-to-date share price return of 23.29%, alongside a 36.48% 1-year total shareholder...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/is-gilead-sciences-gild-fully-valued-on-its-new-hiv-and-canc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/is-gilead-sciences-gild-fully-valued-on-its-new-hiv-and-canc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GILD","LU0965509101.SGD","LU0965509283.SGD","LU1778281490.HKD","LU1934455194.USD","TMED","SG9999015952.SGD","IE00B7SZLL34.SGD","LU1585245621.USD","BK4566","BK4585","SG9999015978.USD","BBH","IE00BZ1G4Q59.USD","IE00B3T34201.USD","BMED","LU2087621335.USD","LU0889565916.HKD","LU2324357040.USD","BK4568","BK4532","LU0882574055.USD","LU2089984988.USD","SG9999015986.USD","IBB","LU0114720955.EUR","BK4588","IBBQ","LU1674673428.USD","MEDI","TBXU","LU1023059063.AUD","LU1061106388.HKD","LU1066053197.SGD","LU0109394709.USD","LU0122379950.USD","LU1066051498.USD","LU1934455863.HKD","LU0823416689.USD","BIB","BK4578","IE00B19Z3581.USD","LU0058720904.USD","BK4139","IE0002270589.USD","LU1037948541.HKD","LU1674673691.USD","LU2112291526.USD","LU0289739699.SGD","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664081594","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664081594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664081594?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:50","pubTimestamp":1788346221,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alumis-inc-alms-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alumis-inc-alms-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2112291526.USD","IE00B19Z3B42.SGD","PBE","LABU","LU0162691827.USD","LU0158827948.USD","LU0496365809.HKD","LU2023251221.USD","IE00B3T34201.USD","LU0234570918.USD","LU1093756325.SGD","BBH","LU1291159041.SGD","VRTX","IBBQ","VERX","TBXU","LU1061106388.HKD","IE0002141913.USD","LU0128526141.USD","LU0265550946.USD","BK4581","LU1674673691.USD","LU2456880835.USD","LU1506573853.SGD","HCSG","LU2089283258.USD","BIB","IBB","LU1116320901.HKD","SG9999001176.SGD","BK4139","LU0106261372.USD","LU0314106906.USD","IE0009355771.USD","LU0265550359.USD","LU1778281490.HKD","IE00B894F039.SGD","XLV","LU1057294990.SGD","XBI","BK4533","MDT","IE00B2B36J28.USD","IDNA","GNMX","LU0058720904.USD","ALMS","BK4588","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664589238","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2664589238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664589238?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:40","pubTimestamp":1788334818,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Cabaletta Bio (CAB...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-322?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-322?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU2324357040.USD","LU0757428866.USD","LU0029874061.USD","LU0289739699.SGD","GNMX","IE00B19Z3B42.SGD","VERX","LU2417539215.USD","LU0432979614.USD","IBBQ","LABU","SG9999001176.USD","SG9999013999.USD","HCSG","BIB","LU0061475181.USD","VRTX","IE00BZ9MQY76.HKD","IE00B19Z3581.USD","LU1674673428.USD","LU2456880835.USD","BK4137","IE00BJJMRZ35.SGD","TBXU","XLV","XBI","IE00B4R5TH58.HKD","IDNA","LU0823416689.USD","LU0109394709.USD","LU1585245621.USD","PBE","LU0566484027.USD","LU0079474960.USD","IBB","BK4533","LU0889565916.HKD","BBH","LU1674673691.USD","LU1035775433.USD","LU1093756325.SGD","IE00B2B36J28.USD","LU2468319806.SGD","IE00B19Z9P08.USD","LU0320765992.SGD","LU0234570918.USD","BK4581","BK4567","LU2362540622.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664689541","title":"What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664689541","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664689541?lang=en_us&edition=fundamental","pubTime":"2026-09-02 10:23","pubTimestamp":1788315823,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals completed its acquisition of Crinetics Pharmaceuticals (NasdaqGS:CRNX), resulting in Crinetics becoming a wholly owned subsidiary.\nCrinetics has been delisted from the Nasdaq, with leadership changes announced as part of its integration into Vertex's operations.\nThe transaction ends Crinetics' status as an independent public company and shifts its future direction under Vertex's control.\n\nFor readers tracking consolidation in biopharma and looking for more stock ideas...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/what-does-crinetics-pharmaceuticals-crnx-delisting-mean-afte","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/what-does-crinetics-pharmaceuticals-crnx-delisting-mean-afte","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0234570918.USD","IE00B2B36J28.USD","LU2417539215.USD","BK4007","LU2237438978.USD","BK4567","LU1093756325.SGD","VERX","IE00BFTCPJ56.SGD","LU0061475181.USD","IE00B19Z9Z06.USD","LU2362540622.SGD","SGXZ57979304.SGD","IDNA","IE0002141913.USD","CRNX","LU1093756168.USD","GNMX","LU2456880835.USD","LU1674673428.USD","BIB","LU0432979614.USD","BK4588","SG9999001176.SGD","LU2462157665.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU0058720904.USD","LU1035775433.USD","LU1585245621.USD","VRTX","IBB","PBE","IBBQ","BK4023","BBH","IE00BZ9MQY76.HKD","TBXU","LU1430594728.SGD","IE00BJT1NW94.SGD","BK4139","LU1815336091.USD","LU0256863811.USD","LU0109394709.USD","LU0417517546.SGD","BK4533","IE0002270589.USD","IE0009355771.USD","BK4585","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664743862","title":"FedEx Incheon Gateway Wins IATA CEIV Pharma Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=2664743862","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664743862?lang=en_us&edition=fundamental","pubTime":"2026-09-02 08:30","pubTimestamp":1788309037,"startTime":"0","endTime":"0","summary":"FedEx Incheon Gateway wins IATA CEIV Pharma certificationFedEx’s Incheon Gateway at Incheon International Airport secured IATA CEIV Pharma certification for temperature-controlled pharmaceutical air c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL7spGmF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","LU1571399168.USD","BIB","LU0823416689.USD","BBH","BK4585","IE00B19Z3B42.SGD","LU0006061336.USD","IE00B4R5TH58.HKD","LU0072461881.USD","LU0109394709.USD","HULL","LU0058720904.USD","SGXZ57979304.SGD","LU0061475181.USD","IE0002270589.USD","BK4533","SHPP","BK4139","IE00BFTCPJ56.SGD","IDNA","LU0432979614.USD","LU1069344957.HKD","LU1267930227.SGD","LU2236285917.USD","IE00B19Z3581.USD","TBXU","IE0002141913.USD","LU1035775433.USD","VRTX","LU2456880835.USD","PBE","LU1674673691.USD","IBB","LU1430594728.SGD","IE00B19Z9Z06.USD","LU1093756325.SGD","GNMX","LU2417539215.USD","LU1585245621.USD","IBBQ","LU2362541273.HKD","FDX","LU0234570918.USD","SG9999001176.SGD","LU1778281490.HKD","LU0251142724.SGD","LU2089984988.USD","LU0310800965.SGD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664999869","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2664999869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664999869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:35","pubTimestamp":1788294900,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 2.45% to $149.92 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.71% to 7,631.47 and Dow Jones Industrial Average  falling 0.79% to 52,766.88.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 4.69% short of its 52-week high of $157.29, which the company reached on February 11th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  rose 2.01% to $271.19, Pfizer Inc.  rose 0.32% to $28.55, and Abbott Laboratories  fell 1.30% to $108.93.Trading volume  remained 2.1 million below its 50-day average volume of 6.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 1, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","IBBQ","LU0114720955.EUR","LU0058720904.USD","BK4532","LU1066053197.SGD","BK4578","LU1585245621.USD","LU2357627491.SGD","IE00B19Z3581.USD","LU0234570918.USD","LU0965508806.USD","LU0882574055.USD","BMED","LU1057294990.SGD","LU0122379950.USD","LU0965509101.SGD","LU1674673428.USD","LU2087621335.USD","BBH","LU1023059063.AUD","LU2112291526.USD","IE00B19Z3B42.SGD","LU0965509283.SGD","LU2468319806.SGD","BK4139","IE00BKVL7J92.USD","LU2089984988.USD","LU0823416689.USD","LU1934455863.HKD","LU0320765992.SGD","IBB","SG9999015945.SGD","BK4550","LU0889565916.HKD","LU0861579265.USD","LU0965509010.AUD","TMED","IE0002270589.USD","LU0109394709.USD","LU1430594728.SGD","LU1571399168.USD","IE00BSNM7G36.USD","LU0859254822.USD","LU1066051498.USD","GILD","TBXU","LU1061106388.HKD","BK4566","BK4583","BIB","BK4585","LU1674673691.USD","BK4568","LU1934455277.USD","LU2324357040.USD","LU1778281490.HKD","MEDI","SG9999015952.SGD","LU1037948541.HKD","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU1839511570.USD","IE00B3T34201.USD","LU1934455194.USD","SG9999015978.USD","SG9999015986.USD","LU1037948897.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664901869","title":"Moderna Inc. Stock Advances 9.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2664901869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664901869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:33","pubTimestamp":1788294780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rallied 9.9% to $154.27 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,099.77 and Dow Jones Industrial Average falling 0.8% to 52,766.88.This was the stock's second consecutive day of gains.Moderna Inc. closed 12.7% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 2.0% to $271.19, Pfizer Inc. rose 0.3% to $28.55, and Gilead Sciences Inc. rose 2.45% to $149.92.Trading volume totaled 25.3 million, compared to the 50-day average of 16.8 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","TBXU","IBBQ","LU0109394709.USD","LU1037948541.HKD","BIB","BK4139","SG9999015945.SGD","LU0289739699.SGD","BK4583","LU1571399168.USD","IE00B7SZLL34.SGD","BK4501","BK4568","LU1934455194.USD","BK4551","LU0965509010.AUD","MRNA","BMED","BK4534","LU2324357040.USD","MRNY","BK4566","LU2468319806.SGD","LU1934455277.USD","BK4533","IE00BZ1G4Q59.USD","LU1057294990.SGD","LU0058720904.USD","IBB","LU0234570918.USD","IE00B19Z3B42.SGD","GNOM","BBH","LU0861579265.USD","LU1934455863.HKD","WDNA","LU0823416689.USD","LGHT","LU1430594728.SGD","LU0965508806.USD","IDNA","TMED","LU1066053197.SGD","MRNX","GILD","BK4588","MEDI","LU0320765992.SGD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664866385","title":"Investors Shrug Off Good News for Heart Patients from New Meds","url":"https://stock-news.laohu8.com/highlight/detail?id=2664866385","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664866385?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:27","pubTimestamp":1788290820,"startTime":"0","endTime":"0","summary":"This year's run in drug stocks gained vigor from new treatments for heart attacks and strokes. Maybe some of those stocks are losing wind.At this past weekend's congress of the European Society of Car","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BBH","BIB","LU2468319806.SGD","AMGN","BK4611","BK4588","IBBQ","LU0320765992.SGD","LU2112291526.USD","LU1061106388.HKD","LU2242652126.USD","LU1861559042.SGD","BK4585","IE0002141913.USD","BK4139","LU2242646821.SGD","PJP","BK4566","IE0009355771.USD","IE00BJJMRZ35.SGD","SG9999001440.SGD","LU0109394709.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","ARKG","LU0289739699.SGD","LU2089984988.USD","BK4599","LU0122379950.USD","IBB","ISBC","LU0868494617.USD","LU0889565916.HKD","LU1023059063.AUD","LU1057294990.SGD","LU1571399168.USD","BK4533","LU1983299246.USD","LU1861558580.USD","BK4534","BK4556","IE00B4R5TH58.HKD","TBXU","CRSP","BK4581","PBE","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854756","title":"Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854756","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854756?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:51","pubTimestamp":1788270662,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  has completed its acquisition of Crinetics Pharmaceuticals , Vertex said on Tuesday.Following the acquisition's closing, Jonathan Poole will take over Vertex's chief financial officer role, effective Jan. 1, Vertex said. Poole currently serves as Vertex's senior vice president for finance, the company said.Charles Wagner, chief operating and financial officer of Vertex, will expand his COO role to head Crinetics' integration, effective immediately, Vertex said.Price: 549.07, Change: +4.55, Percent Change: +0.83","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ9MQY76.HKD","IE0009355771.USD","BIB","VRTX","BK4567","TBXU","LU1674673691.USD","IE00B894F039.SGD","IE0002270589.USD","LU0889565916.HKD","LU2089984988.USD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","IBB","LU2362541273.HKD","IBBQ","LU0320765992.SGD","LU0289739699.SGD","LU2456880835.USD","LU2468319806.SGD","PBE","LU2236285917.USD","VERX","LU0079474960.USD","IE00B19Z9P08.USD","LU0566484027.USD","BK4532","BK4139","LU1778281490.HKD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU1559883803.SGD","BBH","IDNA","IE00B19Z3B42.SGD","LU0823416689.USD","LU0432979614.USD","IE00B19Z9Z06.USD","LU0058720904.USD","LU0234570918.USD","IE00B2B36J28.USD","CRNX","LU1093756325.SGD","LU0417517546.SGD","LU0757428866.USD","LU1430594728.SGD","LU1069344957.HKD","GNMX","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664144854","title":"Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664144854","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664144854?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:25","pubTimestamp":1788269142,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) announced the successful completion of the acquisition of Crinetics Pharmaceuticals (CRNX). Vertex also announced the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-completes-acquisition-of-crinetics-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-completes-acquisition-of-crinetics-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0757428866.USD","IE00BJJMRZ35.SGD","LU0079474960.USD","IE00B19Z3581.USD","LU0109394709.USD","GNMX","IE00B894F039.SGD","LU2468319806.SGD","CRNX","IE00BJT1NW94.SGD","BIB","LU0417517546.SGD","LU0889565916.HKD","IE0002141913.USD","LU0256863811.USD","LU0061475181.USD","BK4567","IE00BZ9MQY76.HKD","LU0320765992.SGD","BBH","LU1430594728.SGD","IE00B4R5TH58.HKD","IE00B19Z9P08.USD","LU1093756325.SGD","VRTX","LU1815336091.USD","LU1093756168.USD","BK4023","LU2362541513.USD","LU0058720904.USD","VERX","IBBQ","SG9999001176.USD","LU0432979614.USD","IBB","SGXZ57979304.SGD","BK4007","LU1035775433.USD","IDNA","LU2236285917.USD","IE00B2B36J28.USD","PBE","SG9999013999.USD","LU2237438978.USD","LU0823416689.USD","TBXU","LU1674673428.USD","LU2462157665.USD","LU2089984988.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851485","title":"Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851485","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851485?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:04","pubTimestamp":1788267895,"startTime":"0","endTime":"0","summary":"Vertex names Jonathan Poole CFO effective Jan. 1, 2027Vertex expanded its executive leadership team following the close of its Crinetics acquisition on Sept. 1, 2026.Charles Wagner, EVP and chief oper","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL4Tv8z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","IE0009355771.USD","LU1778281490.HKD","LU2462157665.USD","BIB","IE00BZ9MQY76.HKD","LU1057294990.SGD","AMGN","SG9999013999.USD","IE00B19Z3B42.SGD","BK4139","IE00BJT1NW94.SGD","IBB","LU0289739699.SGD","LU0109394709.USD","LU1585245621.USD","TBXU","PBE","LU0432979614.USD","LU1023059063.AUD","LU2468319806.SGD","BK4566","LU2362540622.SGD","BK4581","SG9999001176.USD","IE00B19Z9Z06.USD","LU2089984988.USD","IE00B2B36J28.USD","BBH","EVLO","BK4599","IBBQ","BK4588","LU0061475181.USD","LU1093756168.USD","IE00B894F039.SGD","PJP","VRTX","BK4532","IDNA","LU0234570918.USD","LU1035775433.USD","LU2362541273.HKD","SGXZ57979304.SGD","LU1093756325.SGD","BK4567","GNCAQ","IE00B19Z9P08.USD","GNMX","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664117851","title":"Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2664117851","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664117851?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:03","pubTimestamp":1788267780,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA44TDY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJJMRZ35.SGD","LU0320765992.SGD","BIB","LU2324357040.USD","LU0823416689.USD","BBH","BK4532","BK4585","SGXZ57979304.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","IE0002270589.USD","LU2362541513.USD","LU1674673428.USD","BK4139","BK4567","IE00BZ9MQY76.HKD","IE00B894F039.SGD","IDNA","LU0432979614.USD","LU2236285917.USD","IE00BJT1NW94.SGD","IE00B19Z3581.USD","LU0289739699.SGD","TBXU","IE0002141913.USD","LU1035775433.USD","VRTX","LU2456880835.USD","PBE","LU1674673691.USD","LU0079474960.USD","IBB","LU1430594728.SGD","IE00B19Z9Z06.USD","LU2417539215.USD","GNMX","LU1585245621.USD","IBBQ","BK4588","IE00B2B36J28.USD","LU0417517546.SGD","LU0234570918.USD","LU1093756168.USD","SG9999001176.SGD","LU1778281490.HKD","LU2468319806.SGD","IE00B19Z9P08.USD","LU2089984988.USD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000BZT7R73.USD","BMY","IE00BKVL7J92.USD","LU2111349929.HKD","LU1894683348.USD","LU1221951046.USD","LU1718418525.SGD","LU2087625088.SGD","IE00BLSP4452.SGD","LU1074936037.SGD","LU2403377893.USD","SG9999018865.SGD","SG9999017495.SGD","NVS","LU2108987350.USD","LU2552382132.HKD","LU1066053197.SGD","LU2471134952.CNY","LU2360106947.USD","LU0661504455.SGD","LU1989772923.USD","LU1712237335.SGD","SG9999014914.USD","LU0072461881.USD","LU2756315318.SGD","LU1988902786.USD","BK4533","LU0124676726.USD","BK4588","LU2028103732.USD","LU2347655156.SGD","BK7067","MEDI","LU0238689110.USD","IE0002141913.USD","LU0154236417.USD","LU0321505439.SGD","LU1974910355.USD","LU0943347566.SGD","NVO","LU1059921491.USD","IE00B4R5TH58.HKD","LU1201861249.SGD","IE00B4JS1V06.HKD","IE00BFXG1179.USD","LU2023250843.SGD","04332","LU1232071149.USD","LU0158827781.USD","LU0162691827.USD","LU0234572021.USD","IE00BK4W5L77.USD","LU1267930490.SGD","SG9999014880.SGD","SG9999014559.SGD","IE00B19Z3581.USD","LU1116320737.USD","IE00BKPKM429.USD","BK4585","LU0965509101.SGD","LU1127390331.HKD","HRTS","LU0417517546.SGD","IE00BFSS8Q28.SGD","BMED","LU0345769631.USD","LU0994945656.USD","LU0787776722.HKD","LU0511384066.AUD","IE000MB6IJN5.SGD","LU1228905540.USD","LU1868837300.USD","LU2087621335.USD","LU2133065610.SGD","SGXZ31699556.SGD","IBB","LU0949170772.SGD","LU2324357040.USD","LU1979441026.SGD","LU2360032135.SGD","AZN","LU1066051225.USD","BK4566","IE000SO60NU8.SGD","LU1244550221.USD","LU0965508806.USD","LU1778281490.HKD","LU0306806265.USD","IE00BVYPNW00.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0545562505.USD","IE000F7OJYX1.SGD","SGXZ99366536.SGD","SG9999014542.SGD","IE0009355771.USD","LU1267930813.SGD","BIB","LU0203347892.USD","XLV","LU0256863811.USD","RXL","GSK","LU0109394709.USD","LU2362541273.HKD","SGXZ80539844.SGD","LU2596442595.SGD","SGXZ57979304.SGD","LU2750360641.GBP","SG9999011175.SGD","SG9999015358.SGD","LU1280957306.USD","IE00B7SZLL34.SGD","LU0094547139.USD","LU0820561909.HKD","PFE","LU0158827948.USD","LU0708995401.HKD","LU1868837136.USD","IE0000B7K699.USD","LU0079474960.USD","LU1035775433.USD","LU0738911758.USD","SG9999002224.SGD","LU0316494557.USD","LU0267386448.USD","LU0882574055.USD","LU0640476718.USD","LU0820562030.AUD","LU1804176565.USD","BK4599","LU0320765489.SGD","LU1244550577.SGD","BBH","LU2357627491.SGD","LU0868494708.USD","MRK","LU1674673428.USD","NVOC","IE00BN8TJ469.HKD","LU0097036916.USD","LU0354030438.USD","LU2125909593.SGD","LU1720051108.HKD","LU0170899867.USD","LU0964807845.USD","LU0820561818.USD","LU1037948897.HKD","NVOH","LU2211815571.USD","LU1066051811.HKD","LU1732799900.SGD","LU2112291526.USD","LU2462157665.USD","LU1093756168.USD","LU0061475181.USD","LU0689626769.HKD","LU0320765646.SGD","IE00BJLML261.HKD","LU0211327993.USD","LU2347655073.USD","BK4516","LU0912757837.SGD","LU1366192091.USD","LU2505996681.GBP","SG9999014575.USD","LU0310799852.SGD","LU2264538146.SGD","IE00B2B36J28.USD","LU1023059063.AUD","LU1003077747.HKD","LU0965509283.SGD","LU0211331839.USD","LU1496350171.SGD","LU1670710661.SGD","FHLC","LU1066051498.USD","THNR","LU1196500208.SGD","LU1244550494.USD","LU0225771236.USD","FTXH","MHIP","IE00BFSS7M15.SGD","LU0265550946.USD","CURE","LU1093756325.SGD","LU1670710588.SGD","LU2461242641.AUD","LU1868836914.USD","LU2491050071.SGD","LU0795875169.SGD","LU1228905037.USD","LU1934455194.USD","LU1267930730.SGD","BK0239","REGN","LU0466842654.USD","LU0859254822.USD","LU2468319806.SGD","BK4007","LU0234570918.USD","IE00BJJMRX11.SGD","LU2023251221.USD","LU1064131342.USD","LU1914381329.SGD","LU2237438978.USD","LU0069063385.USD","LU0889566641.SGD","LU0553294199.USD","LU2756315664.SGD","GILD","IE0004445239.USD","LU0174119429.USD","LU1670711040.USD","LU1236620834.HKD","LU1989771016.USD","LU0868494617.USD","IXJ","TRUH","LU1236620750.USD","LU2487616109.SGD","AZNH","LU0889565916.HKD","LU1116320901.HKD","IE0004445015.USD","IE00BVYPNV92.GBP","LU0708994859.HKD","IE00B7KXQ091.USD","IE0034235303.USD","LU1934455277.USD","LU0471298694.HKD","LU2089283258.USD","LU0130517989.USD","AMGN","LU1670711123.USD","LU1043141396.HKD","LU0029864427.USD","LU1551013342.USD","LU1670628061.USD","LU1868836591.USD","SG9999015986.USD","SG9999018857.SGD","LU0353189680.USD","LU2168564222.USD","LU1145028129.USD","SG9999013999.USD","BK4532","SG9999015952.SGD","IE000WAW04H5.SGD","IE00BWXC8680.SGD","LU0320765059.SGD","IE00BLSP4239.USD","LU2265009873.SGD","CSL.AU","BK4592","LU0980610538.SGD","LU0683600562.USD","LU2168564065.EUR","LU0114720955.EUR","LU2471134879.HKD","IYH","LU2746668974.SGD","LU1623119135.USD","AGNG","LU0130102774.USD","LU0385154629.USD","LU1221951129.SGD","GSK.UK","LU0426412945.USD","LU0823434740.USD","LU0058720904.USD","LU2746668461.USD","LU0098860793.USD","LU2462591350.SGD","LU2089984988.USD","LU0225284248.USD","LU2242652126.USD","LLY","688235","IE00B1XK9C88.USD","LU2168563687.JPY","LU1629891620.HKD","LU0471298777.SGD","LU2089284900.SGD","SG9999003800.SGD","LU1037948541.HKD","LU2552382215.SGD","BK7501","TBXU","LU1934455863.HKD","IE00BN29S564.USD","LU0006306889.USD","LU0792757196.USD","LU0823416689.USD","LU0726765562.USD","BK4504","LU1323610961.USD","LU1032955483.USD","LU2271345857.HKD","LLYX","LU1506573853.SGD","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU0345769128.USD","LU0942090050.USD","TMED","LU1829250122.USD","SGXZ51526630.SGD","SG9999014567.USD","06160","IE00BJJMRY28.SGD","LU1032466523.USD","LU1261432733.SGD","LU2168564149.EUR","LU2125154778.USD","LU0353189763.USD","LU0395794307.EUR","OZEM","LU2362540622.SGD","LU0070302665.USD","IE00BBT3K403.USD","LU0472753341.HKD","SG9999015945.SGD","LU0265550359.USD","LU0096364046.USD","LU0256863902.USD","LU2168564495.EUR","IHE","LU1035773651.USD","LU1069344957.HKD","LU2505996509.AUD","IE00B19Z3B42.SGD","IE00BGHQF631.EUR","LU1699723380.USD","WDNA","LU1496350502.SGD","SG9999001176.SGD","PAWZ","LU1814569148.SGD","VHT","LU1917777945.USD","LU2213496289.HKD","SG9999001176.USD","IE00B775H168.HKD","BK4139","LU0237698245.USD","SG9999014906.USD","BK4578","LU2129689605.HKD","LU2417539215.USD","GDOC","LU0672654240.SGD","LU0266013472.USD","LU1043141123.HKD","LU1989772840.SGD","LU2433249047.HKD","LU0203202063.USD","PBE","IE00B3PB1722.GBP","LU1941712264.USD","LLYZ","LU0456855351.SGD","CANC","LU0648001328.SGD","BK7508","BK7511","LU2491049909.HKD","LU1894683264.USD","LLII","LU0965509010.AUD","LU0203201768.USD","IE0001KFT4U8.USD","LU1983299246.USD","LU0128525929.USD","BBIO","LU2237443549.SGD","LU2602419157.SGD","LU2361044865.SGD","LU2357305700.SGD","LU0310800379.SGD","ELIS","IE0002270589.USD","LU1941712348.USD","LU2471134523.USD","JDOC","BK4581","GLAM","LU2592432038.USD","PJP","LU0545039389.USD","LU2129689514.USD","IE000M9KFDE8.USD","LU2125154935.USD","LU0786609619.USD","LU0861579265.USD","PPH","SG9999015978.USD","LU1691799644.USD","LU0106261372.USD","LU0795875086.SGD","LU1732800096.USD","LU1839511570.USD","LU0426417589.USD","LU1674673691.USD","LU0345770993.USD","LU2237443622.USD","LU0109391861.USD","LU2362541513.USD","SG9999002232.USD","LU2242646821.SGD","MEDX","SG9999001440.SGD","LU0070217475.USD","IE0005OL40V9.USD","LU0306807586.USD","IE00BSNM7G36.USD","ONC","LU2237443895.HKD","LU0211328371.USD","LU2430703095.HKD","LU0198837287.USD","LU2896262040.SGD","LU0203345920.USD","LU2129689431.USD","LU2456880835.USD","LU0289739343.SGD","IE00BK4W5M84.HKD","LU1121112475.USD","BK4505","IE00B42XCP33.USD","ELIL","IE00BDGV0183.EUR","LU0985320562.USD","LU0882574139.USD","IE00B3T34201.USD","LU0323591593.USD","LU1061106388.HKD","SG9999014898.SGD","IE00BKDWB100.SGD","SGXZ81514606.USD","LU0208291251.USD","NVOX","LU2750360997.AUD","LU2361044949.HKD","LU1670627923.USD","LU2361045086.USD","LU0133085943.USD","LU2430703178.SGD","ILDR","LU2471134796.USD","LU1571399168.USD","ABBV","LU1923622614.USD","BK4559","BK4550","IE00BFTCPJ56.SGD","LU0689472784.USD","LU0345770308.USD","LU0210528500.USD","LU2491050154.USD","LU0122379950.USD","JNJ","LU0985481810.HKD","LU1551013425.SGD","IBBQ","LU0477156953.USD","LU0321505868.SGD","LU0057025933.USD","LU0320765992.SGD","LU1585245621.USD","BK4583","LU1935042991.SGD","LU0354030511.USD","LU1929549753.HKD","LU2430703251.USD","LU0289961442.SGD","LU2552382058.USD","BK4568","LU0225283273.USD","LU2236285917.USD","LU0432979614.USD","LU1883839398.USD","LU1548497426.USD","GSKH","LU2023250330.USD","LU1720051017.SGD","LU2125909247.SGD","SG9999015341.SGD","LU2063271972.USD","LU2237443978.SGD","LU2237443382.USD","BK4534","LU1868836757.USD","GB00BDT5M118.USD","LU0823434583.USD","LU2023250504.SGD","LU2106854487.HKD","LU1069347547.HKD","LU0210536198.USD","LU2237443465.HKD","IE00B1BXHZ80.USD","LU0053666078.USD","LU1162221912.USD","LU1291159041.SGD","LU1267930573.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664385377","title":"UK Regulator Suspends Avacopan Vifor for New Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385377","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664385377?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:03","pubTimestamp":1788260615,"startTime":"0","endTime":"0","summary":"The UK's health regulator has suspended the use, supply and sale of Avacopan Vifor, previously known as Tavneos, for new patients from Sept. 1, the watchdog said Tuesday.The Medicines and Healthcare products Regulatory Agency said available evidence no longer supports a positive benefit-risk balance for the medicine, which is used to treat some rare autoimmune diseases affecting small blood vessels.Tavneos was originally developed by ChemoCentryx, which was acquired by Amgen  in 2022, according to Amgen's website.The regulator said it reached its decision after reviewing all available evidence, advice from the Commission on Human Medicines, and feedback from patients and healthcare professionals.The supply will be allowed to existing patients during a six-month managed withdrawal period to allow safe alternative treatment options, the regulator said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009355771.USD","IE00B4R5TH58.HKD","BK4585","IE0002141913.USD","BIB","BK4534","LU0058720904.USD","LU1057294990.SGD","AMGN","BK4139","LU2242652126.USD","IE00BJT1NW94.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","IBB","LU0289739699.SGD","LU0109394709.USD","LU1061106388.HKD","TBXU","PBE","LU1023059063.AUD","LU1983299246.USD","LU2468319806.SGD","BK4566","BK4581","LU0320765992.SGD","LU0889565916.HKD","LU2089984988.USD","LU2242646821.SGD","IE00B2B36J28.USD","BBH","IE00BFTCPJ56.SGD","BK4599","IBBQ","BK4588","LU2112291526.USD","PJP","SG9999001440.SGD","LU0868494617.USD","BK4533","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664287830","title":"Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664287830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664287830?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:40","pubTimestamp":1788255621,"startTime":"0","endTime":"0","summary":"Goldman Sachs analysts added Vertex Pharmaceuticals (VRTX) to the firm’s US Conviction List as part of its monthly update. Goldman believes Vertex ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-added-to-us-conviction-list-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4504","BBH","IE0002141913.USD","LU0106831901.USD","IE00BJT1NW94.SGD","GNMX","IE0004091025.USD","VERX","LU0868494708.USD","LU1430594728.SGD","SGXZ57979304.SGD","LU2471134796.USD","LU1585245621.USD","IBBQ","IE00B19Z3581.USD","LU2471134952.CNY","PBE","LU0432979614.USD","LU1778281490.HKD","BIB","GSX","LU0417517546.SGD","LU1668664300.SGD","LU2362540622.SGD","VRTX","BK4127","LU0757428866.USD","IE00B2B36J28.USD","IE00B894F039.SGD","LU2471134879.HKD","IE0002270589.USD","LU1815336091.USD","LU2237443895.HKD","LU2362541513.USD","IE0034235188.USD","IE00BZ9MQY76.HKD","LU2237443382.USD","TBXU","IE00BSNM7G36.USD","IDNA","LU1894683264.USD","LU2089984988.USD","LU1868836914.USD","LU2236285917.USD","LU2362541273.HKD","LU1093756325.SGD","LU1035775433.USD","LU0345770993.USD","IE00BFTCPJ56.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664837149","title":"UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September","url":"https://stock-news.laohu8.com/highlight/detail?id=2664837149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664837149?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:29","pubTimestamp":1788254980,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44S0UF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","LU2112291526.USD","LU0289739699.SGD","LU2089984988.USD","PBE","PJP","AMGN","BK4534","LU1061106388.HKD","BK4599","BIB","BK4533","LU0109394709.USD","LU0320765992.SGD","LU1057294990.SGD","LU1571399168.USD","BBH","TBXU","LU1023059063.AUD","LU0868494617.USD","LU0889565916.HKD","BK4588","IBB","LU2468319806.SGD","LU0122379950.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4139","IE00B2B36J28.USD","IE0009355771.USD","SG9999001440.SGD","BK4585","BK4566","BK4581","LU2242652126.USD","LU2242646821.SGD","IE0002141913.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664832384","title":"Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664832384","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664832384?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:18","pubTimestamp":1788250703,"startTime":"0","endTime":"0","summary":"Amgen (NasdaqGS:AMGN) reported new Phase 3 VESALIUS-CV trial results for Repatha (evolocumab) showing a reduction in risk of death for high-risk adults without prior heart attack or stroke, presented at the European Society of Cardiology Congress 2026.\nThe findings extend evidence for Repatha to a broader high-risk population beyond patients with established cardiovascular events.\nAmgen highlighted that the data may inform future treatment guidelines and prescribing decisions in...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24816-main-header/1756203123218"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/why-is-amgen-amgn-in-focus-after-new-repatha-survival-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0289739699.SGD","IBBQ","IE0009355771.USD","BK4599","IE00B2B36J28.USD","PJP","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0122379950.USD","BK4533","BBH","LU1023059063.AUD","LU2112291526.USD","BK4534","LU2468319806.SGD","BK4139","LU2242646821.SGD","LU1983299246.USD","AMGN","LU2089984988.USD","LU0320765992.SGD","IBB","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1571399168.USD","BK4581","PBE","TBXU","BK4566","BIB","BK4585","LU2242652126.USD","LU0868494617.USD","LU0058720904.USD","IE0002141913.USD","SG9999001440.SGD","LU1061106388.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838571","title":"Vertex Advances Share Buyback, Acquires 445,500 Shares by August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838571?lang=en_us&edition=fundamental","pubTime":"2026-09-01 12:22","pubTimestamp":1788236545,"startTime":"0","endTime":"0","summary":"Vertex Corp. ( ($JP:5290) ) has provided an announcement. Vertex Corporation reported the progress of its ongoing share buyback program, authorized...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1778281490.HKD","LU0320765992.SGD","LU1674673428.USD","BRKC","LU2237438978.USD","IE0002141913.USD","LU0417517546.SGD","LU1585245621.USD","VRTX","ACTV","BK4139","BBH","BRKL","LU0889565916.HKD","LU0757428866.USD","LU1815336091.USD","IBB","IE00B19Z9P08.USD","LU0109394709.USD","LU1069344957.HKD","LU2456880835.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","VERX","SG9999001176.USD","IE00BJT1NW94.SGD","BRKD","BK4567","LU0061475181.USD","LU1430594728.SGD","LU2362541513.USD","LU2462157665.USD","IE00BZ9MQY76.HKD","ACKY","IE00B2B36J28.USD","BIB","IE00BJJMRZ35.SGD","BRKU","LU1559883803.SGD","IBBQ","BRKW","LU0256863811.USD","LU0058720904.USD","LU1035775433.USD","TBXU","LU0234570918.USD","GNMX","PBE","BK4588","IDNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}